GLP‑1 dosing schedules (for logging & reminders)

Common dose‑escalation patterns from U.S. FDA labels — written for tracking, not prescribing.

Important: This page is educational and is not medical advice. Dosing is individualized. If your prescriber’s schedule differs, follow your prescriber. Use this as a reference for what to log, not what to do.

Two things can be true at once:

Tracking tip: When your dose changes, log the date of change and the new dose as separate entries. It makes it much easier to connect symptoms or appetite changes to a specific week.

Semaglutide (Ozempic® / Wegovy®)

Semaglutide brand dosing differs by indication/product. The tables below summarize common label escalation patterns.

Ozempic® (semaglutide) — example escalation (T2D labeling)

Weeks Dose (once weekly) Notes (for tracking)
Weeks 1–4 0.25 mg Starter dose used during initiation (often not considered a maintenance dose).
Week 5+ 0.5 mg Common next step. Some patients remain here; some increase later per clinician.
After ≥4 weeks at 0.5 mg 1 mg (if needed) Escalation step may be used depending on goals/response.
After ≥4 weeks at 1 mg 2 mg (if needed) Some labels/versions include 2 mg as a maximum option (verify your pen/strength).

Wegovy® (semaglutide) — example escalation (weight management labeling)

Weeks Dose (once weekly) Notes (for tracking)
Weeks 1–4 0.25 mg Starter step.
Weeks 5–8 0.5 mg Step 2.
Weeks 9–12 1.0 mg Step 3.
Weeks 13–16 1.7 mg Step 4.
Week 17+ 2.4 mg (maintenance) Typical maintenance dose on label (some patients may remain at 1.7 mg per clinician).

Tirzepatide (Mounjaro® / Zepbound®)

Tirzepatide escalation commonly moves in 2.5 mg steps with ≥4 weeks between increases.

Mounjaro® (tirzepatide) — example escalation

Weeks Dose (once weekly) Notes (for tracking)
Weeks 1–4 2.5 mg Starter step.
Week 5+ 5 mg Common next step.
After ≥4 weeks at current dose Increase by 2.5 mg (if needed) Examples: 7.5 → 10 → 12.5 → 15 mg (per clinician/label limits).

Zepbound® (tirzepatide) — example escalation

Weeks Dose (once weekly) Notes (for tracking)
Weeks 1–4 2.5 mg Starter step.
Week 5+ 5 mg Common next step.
After ≥4 weeks at current dose Increase by 2.5 mg (if needed) Stepwise increases may continue up to label maximum depending on indication/response.

How to track this in Jabbit (without overthinking)

Download Jabbit (App Store)   ·   GLP‑1 injection tracker page

Sources (U.S. FDA label PDFs):

If any of the above links are updated by FDA, prefer the newest label for the most current dosing language.

← Back to Jabbit